Recon: Regeneron seeks EUA for antibody cocktail to prevent COVID; Sanofi to build €400M vaccine site in Singapore

• Regeneron to seek US OK for COVID-19 cocktail to be used for prevention (Reuters) (STAT)
• White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators (Reuters)
• Eli Lilly to focus on selling COVID-19 antibody drug combination (Reuters)
• CEO at troubled vaccine plant received 51 percent compensation boost in 2020 (Washington Post)
• Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back Reimbursement To 340B Providers (BioPharmaDive)
• Sage touts first win in $3B Biogen pact, but safety profile, doubts over data cloud road ahead (Endpoints) (STAT)

• J&J begins COVID-19 vaccine supplies to EU, 50 million doses expected in second quarter: lawmaker (Reuters)
• EU seeks clarification from AstraZeneca on supply shortfalls (Reuters)
• Bulgarian PM reveals price for EU's new vaccine contract with Pfizer (Reuters)
• Sanofi to invest 400 million euros in new vaccine production site in Singapore (Reuters)
• AstraZeneca's diabetes drug Farxiga fails in COVID-19 study (Reuters)
• Four Italian firms can activate bioreactors for vaccine production (Reuters)
• Indian panel gives emergency approval for Russia's Sputnik V vaccine: sources (Reuters)
• India bans Remdesivir exports as coronavirus rages on; rallies continue (Reuters)
• China considers mixing COVID-19 vaccines to boost protection rate (Reuters) (NYTimes) (Politico)
• 'The right path' - Chile defends Sinovac use amid fresh efficacy questions (Reuters)

• South African variant may evade protection from Pfizer vaccine, Israeli study says (Reuters)
• Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 – statement (Reuters)
• Spain's Rovi to make ingredients for Moderna's COVID-19 vaccine (Reuters)
• Asthma drug budesonide speeds recovery for at-home COVID-19 patients (Reuters)
• Australia abandons COVID-19 vaccination targets after new advice on AstraZeneca shots (Reuters)
• South Korea to begin producing Novavax COVID-19 vaccine as early as June (Reuters)
• Rollout of eye-scan test for coronavirus targeted by German firm (Reuters)
• Bharat Biotech to raise Covaxin's production to 12 million a month by July (Economic Times)
• Maduro says Venezuela has secured funds to complete COVAX payment (Reuters)
• Ireland set to restrict use of AstraZeneca vaccine: RTE (Reuters)
• Shhh! It’s a Secret! FDA is Not Providing Key Details in the EUA Templates (FDA Law Blog)

• Clinical study reports hold more details about the side effects of cancer drugs (STAT)
• Revolution Medicines seeks to bolster case for its lead cancer drug (STAT)
• AACR21: iTeos busts out early human data for anti-TIGIT antibody. Is it enough to match up with Roche, Merck? (Endpoints)
• AACR21: Eli Lilly blazes new trail for RET inhibitor, ginning up a response in 9 solid tumor types in early data (Endpoints) (STAT)
• AACR: OncoMyx's engineered rabbit pox virus shows promise in lung cancer model (Fierce)
• AACR: MD Anderson team uncovers new target for blocking mutant KRAS and p53 in pancreatic cancer (Fierce)
• Jazz Pharmaceuticals pushes to expand label on Xywav; FDA eyes October for decision on Seagen's latest ADC (Endpoints)
• AZ showcases data for next-generation PARP inhibitor AZD5305 (PMLive)
• European Medicines Data Standards Offer Business Opportunities For Life Science Firms (Pink Sheet)
• Revised US Approach For Parenteral Drug Leachables Could Prevent Regulatory Missteps (Pink Sheet)
• Sanofi teams with virtual reality biotech on oral Dupixent successor (Endpoints)
• IPO market continues to churn with a pair of Covid-19 biotechs seeking Nasdaq, while mitochondria-focused Reneo debuts (Endpoints)
• Taysha Gene Therapies gears up to approach regulators with a new candidate for a debilitating neurodegenerative disease (Endpoints)
• W.Va. legislators call on Gov. Justice to help rescue Mylan plant in Morgantown (Post-Gazette)

• Italy's DiaSorin strikes $1.8B Luminex buy to add multiplex molecular testing assets (MedtechDive)
• FDA clears its first plug-in AI video system for spotting polyps during colonoscopy (Fierce) (FDA)
• South Korean chipmaker bats US FDA approval of its non-invasive glucose monitoring device (mobihealthnews)
• Activ Surgical lands FDA clearance for imaging device to enhance endoscope observations (Fierce)
• FDA puts Medtronic Valiant Navion stent graft recall in Class I category (MedtechDive) (FDA)
• Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life (FDA)
• Akili to study EndeavorRx as a COVID-19 brain fog treatment (mobihealthnews)

• FTC Says Moving Illumina Suit To Calif. Is Risky Amid COVID (Law360)